Logo for Genetic Analysis

Genetic Analysis Investor Relations Material

Latest events

Logo for Genetic Analysis

Q3 2023

2 Nov, 2023
Logo for Genetic Analysis

Q2 2023

30 Aug, 2023
Access the full event backlog
Slides, Transcripts, and Reports from over 8,000 public companies
Segment Data
Access more data
Revenue by
Expenses by
Genetic Analysis AS's mission is to develop, document, clinically validate and commercialize in vitro diagnostic tests for diagnosis and characterizing of dysbiosis in Irritable Bowel Syndrome and Inflammatory Bowel Disease patients. Genetic Analysis AS will initially focus on new ways to help diagnose IBS-D. The company has developed a non-invasive laboratory test for microbiology that can help to confirm the presence of diarrheal IBS. The intent is to provide improved disease characterization for physicians treating large numbers of dysbiosis patients with IBS or IBD with the goal of helping the physician in the management of these patients.